Baxter International (NYSE:BAX) (NYSE: BAX) is a global medical products company dedicated to saving and sustaining lives. Founded in 1931 by Dr. Ralph Stephens and Dr. Donald Baxter, the company initially focused on intravenous solutions and has since expanded its offerings to include a broad array of products and therapies. Baxter operates through two primary business segments: Hospital Products, which provides infusion systems, parenteral nutrition, and surgical care products; and Kidney Care, delivering dialysis equipment, related disposables, and renal pharmaceuticals.
Today, Baxter’s portfolio encompasses advanced drug delivery systems, biosurgery products, nutritional therapies, and renal care technologies. Its infusion systems facilitate precise delivery of critical medications in hospitals and outpatient settings, while its biosurgery division offers hemostats, sealants, and tissue repair solutions. In kidney care, Baxter supplies hemodialysis and peritoneal dialysis equipment along with dialysis-related disposables and therapies that serve patients with chronic kidney disease at home and in clinical environments.
Headquartered in Deerfield, Illinois, Baxter maintains operations in more than 100 countries across North America, Europe, Latin America, Asia-Pacific, and the Middle East. Under the leadership of Chairman and Chief Executive Officer José E. Almeida, the company emphasizes innovation, operational excellence, and patient-centric solutions. Baxter’s extensive global reach, combined with its commitment to research and development, positions it as a key partner for healthcare providers seeking reliable and effective medical technologies.
